AMAP in Limbo; When Will Quality Really Catch Fire?

The AMA is evaluating how and whether to proceed with its physician accreditation program, which has been unable to gain attention from health plans and hospitals. Credentials verification and site reviews will be completed for physicians who have applied for AMAP certification, but no new applications are being accepted for now.

The goal was for AMAP to relieve health plans of duplicative credentialing processes; eventually, AMA hoped to create an infrastructure to allow comparisons of clinical quality. But AMAP has lured fewer than a dozen clients, prompting one AMA board member to question whether the issue of quality truly resonates.

Whether Americans are paying attention to so-called report cards is still an open question. A Society of Actuaries study concludes that managed care enrollees don't rely on HEDIS or other barometers of quality to choose health coverage. The society acknowledges, however, that the influence of other potentially important variables — such as family members' opinions of plans — on their selections, and the degree to which those variables overpower quality considerations, is not understood.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to or online at

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.